For
the past few years, Loyola University Medical Center has enjoyed bragging
rights as the Chicago area's only lung transplant center.
But now lung transplant chief Dr. Edward Garrity is moving to
the University of Chicago Hospitals and taking much of his team
with him.
Garrity is taking at least two other doctors, along with several
nurses, transplant coordinators and clerical staffers. Garrity plans
to do at least 20 lung transplants a year at the U. of C., beginning
as early as February.
The U. of C. "has a great reputation for research and education
and offers us an opportunity to take our lung transplant program
to another level," Garrity said.
Asked if he had experienced any frustrations at Loyola, Garrity
answered, "I'm not going to get into that. I don't wish to create
any controversy."
Loyola, which has done nearly 500 lung transplants since 1988,
will continue the program and is recruiting replacements, said its
new lung transplant chief, Dr. Charles Alex.
'A win-win'
Loyola should have little difficulty rebuilding its program,
said health industry expert David Dranove of Northwestern University's
Kellogg School of Management.
Having two programs "will be a win-win for the whole region,"
he said.
It's certainly a win for the U. of C. A lung transplant program
is prestigious and "generates a lot of revenue," Dranove said.
Insurance plans generally pay $80,000 to $100,000 for a transplant
and the first year of care, Garrity said.
Loyola did 34 lung transplants last year and has done 37 this
year. "I don't see our numbers dropping," Alex said.
Lungs are among the most difficult organs to transplant. The operation
is complex and, afterward, patients who take anti-rejection drugs
are susceptible to infections from germs in the airways and bloodstream.
About 75 percent of Loyola's lung transplant patients survive
the first year, and about 60 percent live at least five years, Alex
said, adding that this is similar to national averages.
Other doctors coming to the U. of C. include transplant surgeon
Dr. Wickii Vigneswaran and critical care specialist Dr. Sangeeta
Bhorade.
Despite the loss, Loyola's program "is very much alive and thriving,"
Alex said. "They found a few stars, but overlooked the franchise
players."